Suchergebnisse - "1474-0338" OR "1744-764X"

PubPharm (931)

1

Safety of stimulant treatment in attention deficit hyperactivity disorder : Part I

enthalten in: Expert opinion on drug safety | 2009

von Merkel, R. | Kuchibhatla, A.

2

Renal adverse effects of nonsteroidal anti-inflammatory drugs

enthalten in: Expert opinion on drug safety | 2009

von Harirforoosh, S. | Jamali, F.

3

Therapy of inflammatory bowel diseases in pregnancy and lactation

enthalten in: Expert opinion on drug safety | 2009

von Cassina, M. | Fabris, L. | Okolicsanyi, L. | +5

4

Ezetimibe/simvastatin

enthalten in: Expert opinion on drug safety | 2009

von Montecucco, F. | Quercioli, A. | Mach, F.

5

Rechallenge in drug-induced liver injury : the attractive hazard

enthalten in: Expert opinion on drug safety | 2009

von Andrade, R. | Robles, M. | Lucena, M.

6

Safety evaluation of enoxaparin in currently approved indications

enthalten in: Expert opinion on drug safety | 2009

von Meneveau, N.

7

Exploratory safety pharmacology : a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations

enthalten in: Expert opinion on drug safety | 2009

von Cavero, I.

8

Orlistat : current status in clinical therapeutics

enthalten in: Expert opinion on drug safety | 2009

von McClendon, K. | Riche, D. | Uwaifo, G.

9

Octreotide LAR : safety and tolerability issues

enthalten in: Expert opinion on drug safety | 2009

von Bornschein, J. | Drozdov, I. | Malfertheiner, P.

10

A review of acitretin for the treatment of psoriasis

enthalten in: Expert opinion on drug safety | 2009

von Lee, C. | Li, K.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[94]